These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine. Flynn RJ; Williams G Br J Urol; 1996 Oct; 78(4):628-31. PubMed ID: 8944522 [TBL] [Abstract][Full Text] [Related]
3. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology]. de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917 [TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy. Sexton WJ; Benedict JF; Jarow JP J Urol; 1998 Mar; 159(3):811-5. PubMed ID: 9474156 [TBL] [Abstract][Full Text] [Related]
5. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy. Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452 [TBL] [Abstract][Full Text] [Related]
6. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Kaplan SA; Reis RB; Kohn IJ; Shabsigh R; Te AE Urology; 1998 Nov; 52(5):739-43. PubMed ID: 9801091 [TBL] [Abstract][Full Text] [Related]
7. Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs. Watters GR; Keogh EJ; Earle CM; Carati CJ; Wisniewski ZS; Tulloch AG; Lord DJ J Urol; 1988 Dec; 140(6):1417-9. PubMed ID: 3193507 [TBL] [Abstract][Full Text] [Related]
8. Intracavernosal injection therapy with and without sexological counselling in men with erectile dysfunction. van der Windt F; Dohle GR; van der Tak J; Slob AK BJU Int; 2002 Jun; 89(9):901-4. PubMed ID: 12010236 [TBL] [Abstract][Full Text] [Related]
9. New developments in self-injection therapy for erectile dysfunction. Gingell JC Br J Urol; 1998 Apr; 81(4):599-603. PubMed ID: 9598634 [No Abstract] [Full Text] [Related]
10. Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery. Nelson CJ; Hsiao W; Balk E; Narus J; Tal R; Bennett NE; Mulhall JP J Sex Med; 2013 Oct; 10(10):2559-65. PubMed ID: 23898886 [TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis. Raina R; Lakin MM; Thukral M; Agarwal A; Ausmundson S; Montague DK; Klein E; Zippe CD Int J Impot Res; 2003 Oct; 15(5):318-22. PubMed ID: 14562131 [TBL] [Abstract][Full Text] [Related]
12. A comprehensive history of injection therapy for erectile dysfunction, 1982-2023. Porst H; Lewis R; Virag R; Goldstein I Sex Med Rev; 2024 Jun; 12(3):419-433. PubMed ID: 38644056 [TBL] [Abstract][Full Text] [Related]
13. Injections of papaverine and regitine into the corpora cavernosa for erectile dysfunction: clinical results in 60 patients. Nelson RP South Med J; 1989 Jan; 82(1):26-8. PubMed ID: 2463675 [TBL] [Abstract][Full Text] [Related]
14. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis. Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303 [TBL] [Abstract][Full Text] [Related]
15. Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study. Claro Jde A; de Aboim JE; Maríngolo M; Andrade E; Aguiar W; Nogueira M; Nardozza Júnior A; Srougi M Sao Paulo Med J; 2001 Jul; 119(4):135-7. PubMed ID: 11500786 [TBL] [Abstract][Full Text] [Related]
16. [Acceptance of corpus cavernosum auto-injection therapy in long-term treatment of erectile dysfunction]. Derouet H; Caspari D; Münch M; Ziegler M Urologe A; 1991 Nov; 30(6):423-7. PubMed ID: 1771721 [TBL] [Abstract][Full Text] [Related]
17. [Treatment of erectile dysfunction using intracavernous pharmacotherapy]. Rodríguez Vela L; Moncada Iribarren I; Gonzalvo Ibarra A; Sáenz de Tejada y Gorman I Actas Urol Esp; 1998 Apr; 22(4):291-319. PubMed ID: 9658642 [TBL] [Abstract][Full Text] [Related]
18. The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors. Sung HH; Ahn JS; Kim JJ; Choo SH; Han DH; Lee SW Andrology; 2014 Jan; 2(1):45-50. PubMed ID: 24194017 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction. Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]